ABBOTT LABORATORIES for ABBOTT LABORATORIES
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
H.R. 1908, S.1145, Patent Reform Act H.R. 1432, Preserve Access to Affordable Generics Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | INTERNATIONAL TRADE POLICY ADVISOR, US SENATE |
| P CLAUDE BURCKY | N/A |
| ANDREA DURKIN | N/A |
| SARA GARLAND | N/A |
| JASON GROVE | N/A |
| ROSEMARY T HAAS | N/A |
| ELAINE R LEAVENWORTH | N/A |
| JENNIFER M LURAY | N/A |
| HOWARD D SCHOLICK | N/A |
| CYNTHIA B SENSIBAUGH | N/A |
| JOHN M TAYLOR | ASSOCIATE COMMISSIONER, FDA |
| ADELE R WITENSTEIN | N/A |
Agriculture AGR
Implementation of Public Law 108-265, Child Nutrition Improvement And Integrity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | INTERNATIONAL TRADE POLICY ADVISOR, US SENATE |
| P CLAUDE BURCKY | N/A |
| ANDREA DURKIN | N/A |
| SARA GARLAND | N/A |
| JASON GROVE | N/A |
| ROSEMARY T HAAS | N/A |
| ELAINE R LEAVENWORTH | N/A |
| JENNIFER M LURAY | N/A |
| HOWARD D SCHOLICK | N/A |
| CYNTHIA B SENSIBAUGH | N/A |
| JOHN M TAYLOR | ASSOCIATE COMMISSIONER, FDA |
| ADELE R WITENSTEIN | N/A |
Trade (domestic/foreign) TRD
International pharmaceutical market access Free trade agreements World Health Organization initiatives regarding pediatric nutrition International intellectual property protection
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | INTERNATIONAL TRADE POLICY ADVISOR, US SENATE |
| P CLAUDE BURCKY | N/A |
| ANDREA DURKIN | N/A |
| SARA GARLAND | N/A |
| JASON GROVE | N/A |
| ROSEMARY T HAAS | N/A |
| ELAINE R LEAVENWORTH | N/A |
| JENNIFER M LURAY | N/A |
| HOWARD D SCHOLICK | N/A |
| CYNTHIA B SENSIBAUGH | N/A |
| JOHN M TAYLOR | ASSOCIATE COMMISSIONER, FDA |
| ADELE R WITENSTEIN | N/A |
Health Issues HCR
S. 736, Laboratory Test Improvement Act S. 1695, Biologics Price Competition and Innovation Act of 2007 H.R. 1038, S. 623, Access to Life-Saving Medicine Act H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1505, Affordable Biologics for Consumers Act H.R. 2900, S.1082, Food and Drug Administration Revitalization Act S. 976, Genomics and Personalized Medicine Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | INTERNATIONAL TRADE POLICY ADVISOR, US SENATE |
| P CLAUDE BURCKY | N/A |
| ANDREA DURKIN | N/A |
| SARA GARLAND | N/A |
| JASON GROVE | N/A |
| ROSEMARY T HAAS | N/A |
| ELAINE R LEAVENWORTH | N/A |
| JENNIFER M LURAY | N/A |
| HOWARD D SCHOLICK | N/A |
| CYNTHIA B SENSIBAUGH | N/A |
| JOHN M TAYLOR | ASSOCIATE COMMISSIONER, FDA |
| ADELE R WITENSTEIN | N/A |
Medicare/Medicaid MMM
Implementation of Section 302 of Public Law 108-173, Medicare Prescription Drug, Improvement, and Modernization Act of 2003-relating to competitive bidding program for durable medical equipment. Implementation of Title 1 of Public Law 108-173, Medicare Prescription Drug, Improvement and Modernization Act of 2003-relating to Medicare prescrition drug benefit program Implementation of Title V of Public Law 109-171, Deficit Reduction Act H.R. 1321, Medicare Advanced Laboratory Diagnostics Act of 2007 H.R. 1193, S.691, Kidney Care Quality and Education Act of 2007 H.R. 4, S.3, Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 3326, Early Treatment for HIV Act of 2007 Medicare reimbursement for glucose monitoring equipment Implementation of Section 641 of Public Law 108-173, Medicare Prescription Drug, Improvement, and Modernization Act of 2003-relating to demonstration project for self-injectable drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | INTERNATIONAL TRADE POLICY ADVISOR, US SENATE |
| P CLAUDE BURCKY | N/A |
| ANDREA DURKIN | N/A |
| SARA GARLAND | N/A |
| JASON GROVE | N/A |
| ROSEMARY T HAAS | N/A |
| ELAINE R LEAVENWORTH | N/A |
| JENNIFER M LURAY | N/A |
| HOWARD D SCHOLICK | N/A |
| CYNTHIA B SENSIBAUGH | N/A |
| JOHN M TAYLOR | ASSOCIATE COMMISSIONER, FDA |
| ADELE R WITENSTEIN | N/A |
Budget/Appropriations BUD
H.R. 3043, S. 1710, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations for FY2008-relating to chronic kidney disease awareness, funding for state AIDS Drug Assistance programs under the Ryan White Care Act. H.R. 1585, S.1548, National Defense Authorization Act of FY2008-TriCare
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | INTERNATIONAL TRADE POLICY ADVISOR, US SENATE |
| P CLAUDE BURCKY | N/A |
| ANDREA DURKIN | N/A |
| SARA GARLAND | N/A |
| JASON GROVE | N/A |
| ROSEMARY T HAAS | N/A |
| ELAINE R LEAVENWORTH | N/A |
| JENNIFER M LURAY | N/A |
| HOWARD D SCHOLICK | N/A |
| CYNTHIA B SENSIBAUGH | N/A |
| JOHN M TAYLOR | ASSOCIATE COMMISSIONER, FDA |
| ADELE R WITENSTEIN | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.